Body contouring isnt about dramatic weight loss
The FDA announced that Ozempic and Wegovy supply problems had ended and set final deadlines for pharmacies to stop making compounded semaglutide: Individual pharmacy locations: Required to stop by April 22, 2025 Commercial compounding operations: Discontinue production by May 22, 2025 So, compounded semaglutide was not available after May 22, 2025, except in exceptional medical circumstances where standard formulations are ineffective
While Semaglutide GLP-1 can help lose weight effectively for patients within this criteria, you should still follow your physicians recommendations
When to Seek Medical Advice About Bloating Whilst bloating is a common and generally benign side effect of GLP-1 therapy, certain symptoms warrant prompt medical evaluation to rule out more serious complications or conditions requiring intervention
Avoid injecting into areas with scars, bruises, or skin abnormalities
Understanding the why behind the sting is the first step toward a more comfortable experience
